Literature DB >> 12069537

Inherited disorders of mitochondrial fatty acid oxidation: a new responsibility for the neonatologist.

Charles R Roe1.   

Abstract

The disorders of mitochondrial fat oxidation present clinically with three major clinical phenotypes: hypoketotic hypoglycemia, cardiomyopathy, and myopathy. Although these features can present together in some of the disorders, one will be the dominant clinical problem. This review will describe these clinical phenotypes while addressing the diagnostic value of various clinical and laboratory studies which are often used for making these diagnoses. With knowledge of the clinical presentation, these diagnoses can often be made very rapidly and at relatively low cost by more specific laboratory tests. The increasing availability of expanded newborn screening by tandem mass spectrometry as well as prenatal diagnosis for these often fatal disorders now provides the opportunity for pre-symptomatic diagnosis. The neonatologist is now in the unique position of identifying these inherited disorders prior to or during severe symptom onset and has the earliest opportunity to provide successful treatment intervention. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069537     DOI: 10.1053/siny.2002.0097

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  4 in total

1.  CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE.

Authors:  Shruti Sharma; Stephen M Black
Journal:  Drug Discov Today Dis Mech       Date:  2009

2.  Identification and Quantitation of Malonic Acid Biomarkers of In-Born Error Metabolism by Targeted Metabolomics.

Authors:  Chandra Shekar R Ambati; Furong Yuan; Lutfi A Abu-Elheiga; Yiqing Zhang; Vivekananda Shetty
Journal:  J Am Soc Mass Spectrom       Date:  2017-03-17       Impact factor: 3.109

3.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

4.  The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long-Chain Fatty Acid Oxidation Disorders.

Authors:  Sun Ku Lee; Manju Gupta; Jack Shi; Kathleen McKeever
Journal:  Clin Pharmacol Drug Dev       Date:  2021-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.